Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

JOINN Biologics

Request full access

Biologics and CGT CDMO from process development to GMP manufacturing

Daxing District, ChinaFounded 2018Biotech & Life Sciences

About JOINN Biologics

JOINN Biologics (昭衍生物) is a China biopharma CDMO founded in 2018 and headquartered in Beijing Economic-Technological Development Area (Daxing). It provides mammalian cell, microbial fermentation, gene-therapy and ADC CDMO plus formulation services from process development through clinical and commercial GMP manufacturing, with US and China sites supporting global innovators. Parent-group JOINN Laboratories is a listed China preclinical CRO; JOINN Biologics focuses on biologics manufacturing.

Source: Dealroom company data

At a glance

Status
Operational
Employees
48
Open positions
None listed
Dealroom signal
60.6/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Aug 2021 $150M $600M Huagai Capital · Green Pine Capital · Yingke Capital · HT Capital —
SERIES AOther financing Dec 2019 $60M $240M Huagai Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

JOINN Biologics website traffic

Latest recorded traffic for JOINN Biologics is 1.8K monthly website visits, up 28.6% over the last three months. JOINN Biologics's team declined 14.3% over the past year.

Latest monthly visits1.8K 3-month web change+28.6% 1-year team growth-14.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

JOINN Biologics in the Daxing District ecosystem

Live from Dealroom

The JOINN Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Huagai Capital
  • CITIC PE
  • Green Pine Capital
  • Yingke Capital
  • HT Capital
  • Hongtai Aplus
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about JOINN Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See JOINN Biologics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.